Abbott Laboratories (NYSE:ABT) Shares Sold by Narwhal Capital Management
Narwhal Capital Management cut its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 25.9% in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 23,208 shares of the healthcare product maker’s stock after selling 8,115 shares during the quarter. Narwhal Capital Management’s holdings […]
More Stories
GoDaddy (NYSE:GDDY) Earns “Buy” Rating from Benchmark
Benchmark reissued their buy rating on shares of GoDaddy (NYSE:GDDY – Free Report) in a report issued on Tuesday, Benzinga...
Wells Fargo & Company Cuts Rivian Automotive (NASDAQ:RIVN) Price Target to $11.00
Rivian Automotive (NASDAQ:RIVN – Free Report) had its target price decreased by Wells Fargo & Company from $15.00 to $11.00...
Wells Fargo & Company Boosts Rollins (NYSE:ROL) Price Target to $56.00
Rollins (NYSE:ROL – Free Report) had its target price raised by Wells Fargo & Company from $54.00 to $56.00 in...
Allstate (NYSE:ALL) Given New $216.00 Price Target at UBS Group
Allstate (NYSE:ALL – Free Report) had its price target lifted by UBS Group from $215.00 to $216.00 in a report...
Devon Energy (NYSE:DVN) Earns Hold Rating from Benchmark
Benchmark restated their hold rating on shares of Devon Energy (NYSE:DVN – Free Report) in a research note issued to...
Barclays Raises General Motors (NYSE:GM) Price Target to $64.00
General Motors (NYSE:GM – Free Report) (TSE:GMM.U) had its target price lifted by Barclays from $60.00 to $64.00 in a...